Where? Rome

Polifunctional Room of the Presidency of the Council of Ministers

In collaboration with: ASIS, CNBBSV

The National Committee for Biosafety, Biotechnology and Life Sciences, Assobiotec and ASIS (Associazione Studi sull’Industria della Salute) intend, in this meeting, to take stock of the situation about new scenarios in medicine in areas like oncology, neurology and cardiology and about their repercussions in the health industry. In the course of the meeting doctors, exponents of the industry world, economists and patient associations are going to meet with the aim of understanding how Italy intends to place itself in the next future.

Initial remarks from the President of the Council of Ministers (and/or Minister of Health and/or Minister of Research)

Opening remarks from the CNBBSV President prof. Cuccurullo, the Assobiotec President dr. Sidoli and the ASIS President prof. Macchia

Moderator of the Convention: prof. Cuccurullo


Predictive medicine and networking system: prof. Cuccurullo

The science point of view:

– Cardiology: prof. Condorelli (Milan)

– Neurology: prof. Caltagirone (Rome)

– Oncology: prof. Marchetti (Chieti)

What industry is doing:

– Assobiomedica: ing. Rimondi (President)

– Assobiotec: dr. Sidoli (President)

– Farmindustria: dr. Aringhieri(Biotech Committee Chairman)

The impact on economy:

– Economist: prof. Sargiacomo (Univ. G. D’Annunzio)

Patient’s expectations:

– Cittadinanza Attiva: prof. Frey (President)

(From 9,30 to 13,30)